DESIGN AND SYNTHESIS OF NEW NAPHTHALENIC DERIVATIVES AS LIGANDS FOR 2-[I-125]IODOMELATONIN BINDING-SITES

被引:53
作者
LANGLOIS, M
BREMONT, B
SHEN, S
PONCET, A
ANDRIEUX, J
SICSIC, S
SERRAZ, I
MATHEALLAINMAT, M
RENARD, P
DELAGRANGE, P
机构
[1] ADIR,F-92415 COURBEVOIE,FRANCE
[2] INST RECH INT SERVIER,F-92415 COURBEVOIE,FRANCE
关键词
D O I
10.1021/jm00012a004
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
New melatonin-like agents were designed from the frameworks of 2,5-dimethoxyphenethylamine, an important structural moiety for the 5-HT receptor, and (2-methoxynaphthyl)-ethylamine. The compounds were synthesized by classical methods and evaluated in binding assays with chicken brain membranes using 2-[I-125]iodomelatonin as the radioligand. Preliminary studies on the series of N-acyl-disubstituted phenethylamines showed the favorable role of the methoxy group in the ortho position of the side chain on the affinity for the receptor K-i = 8 +/- 0.2 nM) for N-[2-(2-methoxy-5-bromophenyl)ethyl]propionamide (3o). This effect was confirmed in a series of the naphthalene derivatives, a bioisosteric moiety of the indole ring, and several potent ligands for melatonin binding sites were prepared such as N-[2-(2-methoxynaphthyl)ethyl]propionamide (4b) (K-i = 0.67 +/- 0.05 nM) and N-[2-(2,7-dimethoxynaphthyl)ethyl]cyclopropylformamide (K-i = 0.05 +/- 0.004 nM) (4k). Structure-activity relationships are discussed with regard to melatonin and bioisosteric naphthalenic compound 2. The K-i value for 4b was affected to a similar extent to that of melatonin by GTP-gamma-S or Mn2+ in competition experiments, suggesting an agonist profile for this compound.
引用
收藏
页码:2050 / 2060
页数:11
相关论文
共 58 条
  • [1] Reiter R.J., Pineal melatonin: Cell biology of its synthesis and of its physiological interactions, Endocrinol. Rev., 12, pp. 151-180, (1991)
  • [2] Reiter R.J., The pineal and its hormone in the control of the reproduction in the mammals, Endocrinol. Rev., 1, pp. 109-131, (1980)
  • [3] Reiter R.J., The melatonin rhythm: both a clock and a calendar, Experientia, 49, pp. 654-664, (1993)
  • [4] Pierpaoli W., The pineal gland: a circadian or seasonal aging clock?, Aging, 3, pp. 99-101, (1991)
  • [5] Blehar M.C., Lewy A.J., Seasonal mood disorders: Consensus and controversy, Psychopharmacol. Bull., 4, pp. 465-482, (1990)
  • [6] Waldhauser F., Ehrart B., Forster E., Clinical aspects of the melatonin action: impact of development, aging, and puberty, involvement of melatonin in psychiatric disease and importance of neuroimmunoendocrine interactions, Experientia, 49, pp. 671-681, (1993)
  • [7] Maestroni G.J.M., The immunoneuroendocrine role of melatonin, J. Pineal Res., 14, pp. 1-10, (1993)
  • [8] Ying S.-W., Niles L.P., Crocker C., Human malignant melanoma cells express high-afĭĭnity receptors for melatonin: antiproliferative effects of melatonin and 6-chloromelatonin, Eur. J. Pharmacol. Mol. Pharmacol. Sect., 246, pp. 89-96, (1993)
  • [9] Poeggeler B., Reiter R.J., Tan D.-X., Chen L.-D., Manchester L.C., Melatonin, hydroxyl radical-mediated oxidative damage, and aging: A hypothesis, J. Pineal Res., 14, pp. 151-158, (1993)
  • [10] Grad B.R., Rozencwaig R., The role of melatonin and serotonin in aging: Update, Psychoneuroendocrinology, 18, pp. 283-295, (1993)